Powered by Zeal Technology
Despite its amazing curative properties, the bio-availability and therapeutic applications of β-Caryophyllene are limited because of its highly volatile and lipid soluble nature. Only Rephyll ensures that the bio-active molecule is protected inside the lipid bilayer of the carrier from untimely degradation or inaction, and can easily pass through the cell membrane. The active molecules are delivered at the site of action, increasing its bio-availability, achieving targeted delivery and assuring biological activity. The specific carriers used in Rephyll help encapsulate the hydrophobic bio-active ingredient as liposomes inside a phospholipid moiety using Zeal Technology, which improves its bio-availability and efficacy.
Analgesics are the most commonly prescribed pain-killers, broadly classified into Opioids, Non-Opioids (Non-Steroidal Anti-Inflammatory Drugs – NSAIDs) and Adjuvant Analgesics. All these analgesic drugs are known to have numerous physical and physiological side effects with users exhibiting tolerance, withdrawal and dependency symptoms. In the field of sports, athletes often have to deal with injuries and pain, while painkillers are not typically recommended. This has led to the popularity of a natural and effective pain reliever, with endocannabinoid- β-Caryophyllene, a safe dietary cannabinoid recognised by the USFDA that is gaining attention for its therapeutic effects on pain. Rephyll, made with natural ingredients, ensures increased stability, solubility and bio-availability of β-Caryophyllene with no harmful side effects.